Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

pembrolizumab 30 Capecitabine 24 Bevacizumab 23 Cyclophosphamide 22 Gemcitabine 21 Paclitaxel 20 Nivolumab 19 Fluorouracil 19 Docetaxel 18 aldesleukin 17 Leucovorin 17 Irinotecan 17 Oxaliplatin 15 Interleukin-2 14 Radiosurgery 13 Cisplatin 13 Cetuximab 13 fludarabine 12 Carboplatin 12 Albumin-Bound Paclitaxel 11 fludarabine phosphate 10 Ipilimumab 10 Drug Therapy 10 Doxorubicin 10 Sunitinib 9 Radiotherapy 9 Everolimus 9 130-nm albumin-bound paclitaxel 9 Trastuzumab 8 Temozolomide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasm Metastasis × Chloroquine × Clear all

NCT01894633 2024-01-24

CLQ

Instituto Nacional de Cancerologia de Mexico

Phase 2 Terminated

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡